NEUROFIBROMATOSIS TIPE 1 PADA ANAK DENGAN MANIFESTASI NEUROFIBROMA PLEKSIFORMIS YANG MENYERUPAI NEVUS BECKER
DOI:
https://doi.org/10.33820/mdvi.v47i4.371Keywords:
Neurofibromatosis tipe 1, neurofibroma pleksiformis, nevus BeckerAbstract
Neurofibromatosis type 1 (NF-1) is a genetic disorder with an autosomal dominant inheritance pattern. It is caused by heterozygous mutations of the NF-1 gene located within the chromosome 17q11.2. Plexiform neurofibroma is one of several clinical manifestations that can be found in NF-1 cases. A 10-year-old girl was referred to the Dermatovenereology Clinic of Sanglah Hospital with the suspicion of Becker’s nevus. From the alloanamnesis, there were multiple blackish-brown spots in the left back since she was six months of age. Those spots have begun to thicken and protrude during the past two months. The brown spots appeared and spread into other parts of the body since the patient was four years old. Another complaint from the patient was back pain, starting at the age of 8. Histopathological examination supported the diagnosis of neurofibroma. No specific therapy was given in this case. The patient was then consulted to the orthopedic surgery department for her scoliosis. Eventually, the patient is planned to be consulted to the ophthalmology, pediatric, and neurology department for more comprehensive management.
Downloads
References
2. Listernick R, Charrow J. The neurofibromatoses. Dalam: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, Orringer JS, penyunting. Fitxpatrick’s Dermatology in General Medicine. Edisi ke-9. New York: McGraw-Hill Co;2019.h.2465-77.
7. Ly KI, Blakeley JO. The Diagnosis and Management of Neuro- fibromatosis Type 1. Med Clin North Am. 2019;103(6):1035–54 8. Sabatini C, Milani D, Menni F, Tadini G, Esposito S. Treatment of neurofibromatosis type 1. Curr Treat Options
Neurol. 2015;17(26):2-11.
9. Sayah C, Benmahmoud M, Soualili Z. Neurofibromatosis
Type 1: Case report and review of literature. J Child Dev
Disorders. 2016;2:1-3.
10. Tchernev G, Chokoeva A, Patterson JW, Bakardzhiev I,
Wollina U, Tana C. Plexiform neurofibroma a case report.
Medicine. 2016;95(6):e2663.
11. Rodrigues M, pandya AG. Hypermelanoses. Dalam: Kang S,
Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, Orringer JS, penyunting. Fitzpatrick’s Dermatology in General Medicine. Edisi ke-9. New York: McGraw Hill Co;2019. h.1351-
12. Sadlier M, O’Regan GM. Becker’s nevus. N Engl J Med. 2015;372:1249-50.
13. Patterson JW. Disorders of pigmentation. Dalam: Hosler, GA. Weedon’s Skin Pathology. Edisi ke-4. New York: Elsevier;2016. h.485-6.
14. Dombi E, Baldwin A, Marcus LJ, Fisher MJ, Weiss B, Kim A, dkk. Activity of selumetinib in neurofibromatosis type 1 related plexiform neurofibromas. N Engl J Med. 2016;375(26):2550-60.
15. Patel P, Malik K, Khachemoune A. Sebaceus and Becker’s nevus: overview of their presentation, pathogenesis, associations, and treatment. Am J Clin Dermatol. 2015;16(03):197–204.
16. Adisty DR, Zulkarnain I. Studi Retrospektif: Insidensi dan Penatalaksanaan Genodermatosis. BIKKK. 2016;28(2):35-41.
3. Hurwitz, S. Disorders of pigmentation. Dalam: Paller AS,
Mancini AJ, penyunting. Hurwitz Clinical Pediatric 62.
Dermatology: A Textbook of Skin Disorders of Childhood and
Adolescence. Edisi ke-5. Edinburgh: Elsevier;2016.h.268-72.
4. Avery RA, Katowitz JA, Fisher MJ, Heidary G, Dombi E, Packer RJ, Widemann BC. Orbital/Peri-orbital Plexiform Neurofibromas in Children with Neurofibromatosis type 1: Multi-disciplinary Reccommendations for Care. HHS Public
Access. 2017;124(1):123-32.
5. Ehara Y, Yamamoto O, Kosaki K, Yoshida Y. Natural course
and characteristics of cutaneous neurofibromas in
neurofibromatosis 1. J Dermatol. 2018;45(1):53-7.
6. Canon A, Chen MJ, Li P, Boyd K, Theos A, Redden DT, dkk. Cutaneous neurofibromas in neurofibromatosis type I: a quantitative natural history study. Orphanet J Rare Dis.
2018;13(1):31.
